News for Emergent BioSolutions Stock (EBS)

EBS Investor Alert: Shareholder Class Action Lawsuit Filed

Newsfile Corp • 06/09/21

Class Action Lawsuit Deadline: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Emergent BioSolutions Inc.

PRNewsWire • 06/08/21

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Emergent BioSolutions Inc. Investors with Losses to Secure Counsel Before Important June 18 Deadline in Securities Class Action - EBS

PRNewsWire • 06/05/21

EBS Shareholder Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Shareholders of Emergent BioSolutions Inc. of Deadline in Securities Fraud Class Action Lawsuit

Newsfile Corp • 06/04/21

Entwistle & Cappucci LLP Announces It Has Filed a Securities Class Action Against Emergent BioSolutions Inc. (NYSE: EBS)

Business Wire • 06/03/21

HAGENS BERMAN Encourages Emergent BioSolutions (EBS) Investors to Contact the Firm Now, June 18th Deadline Approaching in Securities Fraud Lawsuit

Newsfile Corp • 06/03/21

Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Securities Fraud Class Action Lawsuit Filed Against Emergent BioSolutions Inc.

PRNewsWire • 06/02/21

CLASS ACTION ALERT: Kessler Topaz Meltzer & Check, LLP Reminds Emergent BioSolutions Inc. Shareholders of Securities Fraud Class Action Lawsuit

Newsfile Corp • 05/31/21

EBS Breaking Notice: Rosen, Trusted National Trial Counsel, Encourages Emergent BioSolutions Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - EBS

Newsfile Corp • 05/29/21

Kessler Topaz Meltzer & Check, LLP: Reminds Investors of Securities Fraud Class Action Filed Against Emergent BioSolutions Inc.

PRNewsWire • 05/28/21

Emergent BioSolutions Poised To Receive FDA Nod to Restart J&J COVID-19 Shot Production at Baltimore Plant After Mishap: WSJ

Benzinga • 05/28/21

EBS INVESTOR REMINDER: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Securities Fraud Class Action Lawsuit Filed Against Emergent BioSolutions Inc.

Newsfile Corp • 05/27/21

Emergent BioSolutions's Single-Dose Chikungunya Vaccine Candidate Effective Even After Two Years of Vaccination

Benzinga • 05/26/21

Emergent BioSolutions Announces Positive Two-Year Persistence Data From Phase 2 Study Evaluating CHIKV VLP, the Company's Chikungunya Virus Virus-Like Particle Vaccine Candidate

GlobeNewsWire • 05/26/21

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Emergent Biosolutions Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 18, 2021 - EBS

Newsfile Corp • 05/25/21

HAGENS BERMAN Encourages Emergent BioSolutions (EBS) Investors to Contact the Firm Now, Securities Fraud Class Action Filed

Newsfile Corp • 05/24/21

Shareholder Alert: Kessler Topaz Meltzer & Check, LLP Reminds Shareholders of Emergent BioSolutions Inc. of Securities Class Action Lawsuit

Newsfile Corp • 05/24/21

Emergent BioSolutions Stock News: Berger Montague Announces Investigation Into Securities Fraud Allegations Against Emergent BioSolutions Inc. (EBS); Lead Plaintiff Deadline is June 18, 2021

Newsfile Corp • 05/23/21

EBS Stock News: Berger Montague Investigates Alleged Securities Fraud Claims Against Emergent BioSolutions Inc. (EBS); Lead Plaintiff Deadline is June 18, 2021

Newsfile Corp • 05/22/21

EBS News: Berger Montague Investigates Securities Fraud Allegations Against Emergent BioSolutions Inc. (EBS); Lead Plaintiff Deadline is June 18, 2021

Newsfile Corp • 05/21/21

Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline for Securities Fraud Class Action Lawsuit Filed Against Emergent BioSolutions Inc.

Newsfile Corp • 05/21/21

Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Emergent BioSolutions Inc. (EBS)

PRNewsWire • 05/20/21

EBS Breaking News: Rosen, Leading Trial Attorneys, Encourages Emergent BioSolutions Inc. Investors to Secure Counsel Before Important June 18 Deadline in Securities Class Action - EBS

Newsfile Corp • 05/19/21

Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Securities Fraud Class Action Against Emergent BioSolutions Inc.

Newsfile Corp • 05/19/21

Emergent CEO says FDA is holding over 100 million J&J Covid vaccine doses for further testing after botched doses

CNBC • 05/19/21